313 related articles for article (PubMed ID: 32117758)
1. The Generation and Identity of Human Myeloid-Derived Suppressor Cells.
Bergenfelz C; Leandersson K
Front Oncol; 2020; 10():109. PubMed ID: 32117758
[TBL] [Abstract][Full Text] [Related]
2. Elucidating granulocytic myeloid-derived suppressor cell heterogeneity during Staphylococcus aureus biofilm infection.
Bertrand BP; Heim CE; Koepsell SA; Kielian T
J Leukoc Biol; 2024 Mar; 115(4):620-632. PubMed ID: 38095415
[TBL] [Abstract][Full Text] [Related]
3. On the origin of myeloid-derived suppressor cells.
Millrud CR; Bergenfelz C; Leandersson K
Oncotarget; 2017 Jan; 8(2):3649-3665. PubMed ID: 27690299
[TBL] [Abstract][Full Text] [Related]
4. Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis.
Li M; Zhu D; Wang T; Xia X; Tian J; Wang S
Front Immunol; 2018; 9():2849. PubMed ID: 30564242
[TBL] [Abstract][Full Text] [Related]
5. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].
Pilatova K; Budinská E; Bensciková B; Nenutil R; Šefr R; Fedorová L; Hanáková B; Brychtová V; Zdražilová Dubská L
Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197
[TBL] [Abstract][Full Text] [Related]
6. Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.
Binsfeld M; Muller J; Lamour V; De Veirman K; De Raeve H; Bellahcène A; Van Valckenborgh E; Baron F; Beguin Y; Caers J; Heusschen R
Oncotarget; 2016 Jun; 7(25):37931-37943. PubMed ID: 27177328
[TBL] [Abstract][Full Text] [Related]
7. Neutrophils as myeloid-derived suppressor cells.
Aarts CEM; Kuijpers TW
Eur J Clin Invest; 2018 Nov; 48 Suppl 2():e12989. PubMed ID: 29956819
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor Cells.
Lee CR; Lee W; Cho SK; Park SG
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29543758
[TBL] [Abstract][Full Text] [Related]
9. Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis.
Uhel F; Azzaoui I; Grégoire M; Pangault C; Dulong J; Tadié JM; Gacouin A; Camus C; Cynober L; Fest T; Le Tulzo Y; Roussel M; Tarte K
Am J Respir Crit Care Med; 2017 Aug; 196(3):315-327. PubMed ID: 28146645
[TBL] [Abstract][Full Text] [Related]
10. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure.
Zhou L; Miao K; Yin B; Li H; Fan J; Zhu Y; Ba H; Zhang Z; Chen F; Wang J; Zhao C; Li Z; Wang DW
Circulation; 2018 Jul; 138(2):181-197. PubMed ID: 29437117
[TBL] [Abstract][Full Text] [Related]
12. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway.
Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen Sulfide Reduces Myeloid-Derived Suppressor Cell-Mediated Inflammatory Response in a Model of
De Cicco P; Sanders T; Cirino G; Maloy KJ; Ianaro A
Front Immunol; 2018; 9():499. PubMed ID: 29636751
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD
Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766
[TBL] [Abstract][Full Text] [Related]
15. Myeloid derived suppressor cells in chronic myeloid leukemia.
Giallongo C; Parrinello N; Brundo MV; Raccuia SA; Di Rosa M; La Cava P; Tibullo D
Front Oncol; 2015; 5():107. PubMed ID: 26029664
[TBL] [Abstract][Full Text] [Related]
16. The recent progress of myeloid-derived suppressor cell and its targeted therapies in cancers.
Ren R; Xiong C; Ma R; Wang Y; Yue T; Yu J; Shao B
MedComm (2020); 2023 Aug; 4(4):e323. PubMed ID: 37547175
[TBL] [Abstract][Full Text] [Related]
17. Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes.
Raychaudhuri B; Rayman P; Huang P; Grabowski M; Hambardzumyan D; Finke JH; Vogelbaum MA
J Neurooncol; 2015 Apr; 122(2):293-301. PubMed ID: 25579983
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
Schmid M; Zimara N; Wege AK; Ritter U
Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
[TBL] [Abstract][Full Text] [Related]
19. Distribution and differentiation of myeloid-derived suppressor cells after fluid resuscitation in mice with hemorrhagic shock.
Jiang JK; Fang W; Hong LJ; Lu YQ
J Zhejiang Univ Sci B; 2017 Jan.; 18(1):48-58. PubMed ID: 28070996
[TBL] [Abstract][Full Text] [Related]
20. CD11b+Gr-1+ myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice.
Foks AC; Van Puijvelde GH; Wolbert J; Kröner MJ; Frodermann V; Van Der Heijden T; Van Santbrink PJ; Boon L; Bot I; Kuiper J
Cardiovasc Res; 2016 Aug; 111(3):252-61. PubMed ID: 27234908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
